FERHEMVY Trademark

Trademark Overview

On Thursday, April 21, 2022, a trademark application was filed for FERHEMVY with the United States Patent and Trademark Office. The USPTO has given the FERHEMVY trademark a serial number of 97375320. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, March 31, 2025. This trademark is owned by COVIS PHARMA GMBH. The FERHEMVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological diseases and conditions

General Information

Serial Number97375320
Word MarkFERHEMVY
Filing DateThursday, April 21, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, March 31, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCOVIS PHARMA GMBH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6300
CH
Party NameCOVIS PHARMA GMBH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Tuesday, May 10, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 25, 2022NEW APPLICATION ENTERED
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Sunday, May 8, 2022ASSIGNED TO LIE
Monday, May 9, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, May 12, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, February 8, 2023ASSIGNED TO EXAMINER
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 1 FILED
Thursday, November 9, 2023SOU EXTENSION 1 GRANTED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, April 24, 2024SOU EXTENSION 2 FILED
Wednesday, April 24, 2024SOU EXTENSION 2 GRANTED
Thursday, April 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 3 FILED
Wednesday, September 4, 2024SOU EXTENSION 3 GRANTED
Monday, March 31, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 31, 2025SOU EXTENSION 4 FILED
Tuesday, April 1, 2025SOU EXTENSION 4 GRANTED
Tuesday, April 1, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ferhemvy diseases conditions hematological treatment preparations pharmaceutical